Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Lane, HC' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 103 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Miller, KD; Spooner, K; Herpin, BR; Rock-Kress, D; Metcalf, JA; Davey, RT; Falloon, J; Kovacs, JA; Polis, RA; Walker, RE; Masur, H; Lane, HC
      Immunotherapy of HIV-infected patients with intermittent interleukin-2: Effects of cycle frequency and cycle duration on degree of CD4(+) T-lymphocyte expansion

      CLINICAL IMMUNOLOGY
    2. Lane, HC; La Montagne, J; Fauci, AS
      Bioterrorism: A clear and present danger

      NATURE MEDICINE
    3. Sereti, I; Lane, HC
      Immunopathogenesis of human immunodeficiency virus: Implications for immune-based therapies

      CLINICAL INFECTIOUS DISEASES
    4. Sereti, I; Herpin, B; Metcalf, JA; Stevens, R; Baseler, MW; Hallahan, CW; Kovacs, JA; Davey, RT; Lane, HC
      CD4 T cell expansions are associated with increased apoptosis rates of T lymphocytes during IL-2 cycles in HIV infected patients

      AIDS
    5. Lane, HC; Fauci, AS
      Bioterrorism on the home front - A new challenge for American medicine

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    6. Imamichi, T; Murphy, MA; Imamichi, H; Lane, HC
      Amino acid deletion at codon 67 and Thr-to-Gly change at codon 69 of humanimmunodeficiency virus type 1 reverse transcriptase confer novel drug resistance profiles

      JOURNAL OF VIROLOGY
    7. Emery, S; Lane, HC; Neaton, JD
      Interleukin-2 in clinical trials: Other factors to be considered - Reply

      JOURNAL OF INFECTIOUS DISEASES
    8. Imamichi, H; Crandall, KA; Natarajan, V; Jiang, MK; Dewar, RL; Berg, S; Gaddam, A; Bosche, M; Metcalf, JA; Davey, RT; Lane, HC
      Human immunodeficiency virus type 1 quasi species that rebound after discontinuation of highly active antiretroviral therapy are similar to the viralquasi species present before initiation of therapy

      JOURNAL OF INFECTIOUS DISEASES
    9. Kovacs, JA; Vogel, S; Metcalf, JA; Baseler, M; Stevens, R; Adelsberger, J; Lempicki, R; Hengel, RL; Sereti, I; Lambert, L; Dewar, RL; Davey, RT; Walker, RE; Falloon, J; Polis, MA; Masur, H; Lane, HC
      Interleukin-2 induced immune effects in human immunodeficiency virus-infected patients receiving intermittent interleukin-2 immunotherapy

      EUROPEAN JOURNAL OF IMMUNOLOGY
    10. Lane, HC; Seeley, S
      Immunologic approaches to the therapy of patients with HIV infection

      RETROVIRAL IMMUNOLOGY: IMMUNE RESPONSE AND RESTORATION
    11. Sereti, I; Gea-Banacloche, J; Kan, MY; Hallahan, CW; Lane, HC
      Interleukin 2 leads to dose-dependent expression of the alpha chain of theIL-2 receptor on CD25-negative T lymphocytes in the absence of exogenous antigenic stimulation

      CLINICAL IMMUNOLOGY
    12. Falloon, J; Piscitelli, S; Vogel, S; Sadler, B; Mitsuya, H; Kavlick, MF; Yoshimura, K; Rogers, M; LaFon, S; Manion, DJ; Lane, HC; Masur, H
      Combination therapy with amprenavir, abacavir, and efavirenz in human immunodeficiency virus (HIV)-infected patients failing a protease-inhibitor regimen: Pharmacokinetic drug interactions and antiviral activity

      CLINICAL INFECTIOUS DISEASES
    13. Gea-Banacloche, JC; Martino, L; Mican, JM; Hallahan, CW; Baseler, M; Stevens, R; Lambert, L; Polis, M; Lane, HC; Connors, M
      Longitudinal changes in CD4(+) T cell antigen receptor diversity and naive/memory cell phenotype during 9 to 26 months of antiretroviral therapy of HIV-infected patients

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    14. Ruxrungtham, K; Suwanagool, S; Tavel, JA; Cheunyam, M; Kroon, E; Ubolyam, S; Buranapraditkun, S; Techasathit, W; Li, YM; Emery, S; Davey, RT; Fosdick, L; Kunanusont, C; Lane, HC; Phanuphak, P
      A randomized, controlled 24-week study of intermittent subcutaneous interleukin-2 in HIV-1 infected patients in Thailand

      AIDS
    15. Orenstein, JM; Bhat, N; Yoder, C; Fox, C; Polis, MA; Metcalf, JA; Kovacs, JA; Falloon, J; Walker, RE; Masur, H; Lane, HC; Davey, RT
      Rapid activation of lymph nodes and mononuclear cell HIV expression upon interrupting highly active antiretroviral therapy in patients after prolonged viral suppression

      AIDS
    16. Davey, RT; Murphy, RL; Graziano, FM; Boswell, SL; Pavia, AT; Cancio, M; Nadler, JP; Chaitt, DG; Dewar, RL; Sahner, DK; Duliege, AM; Capra, WB; Leong, WP; Giedlin, MA; Lane, HC; Kahn, JO
      Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy - A randomized controlled trial

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    17. Lempicki, RA; Kovacs, JA; Baseler, MW; Adelsberger, JW; Dewar, RL; Natarajan, V; Bosche, MC; Metcalf, JA; Stevens, RA; Lambert, LA; Alvord, WG; Polis, MA; Davey, RT; Dimitrov, DS; Lane, HC
      Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4(+) and CD8(+) T cell turnover in HIV-infected patients

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    18. Imamichi, T; Berg, SC; Imamichi, H; Lopez, JC; Metcalf, JA; Falloon, J; Lane, HC
      Relative replication fitness of a high-level 3 '-azido-3 '-deoxythymidine-resistant variant of human immunodeficiency virus type 1 possessing an amino acid deletion at codon 67 and a novel substitution (Thr -> Gly) at codon 69

      JOURNAL OF VIROLOGY
    19. Imamichi, T; Sinha, T; Imamichi, H; Zhang, YM; Metcalf, JA; Falloon, J; Lane, HC
      High-level resistance to 3 '-azido-3 '-deoxythimidine due to a deletion inthe reverse transcriptase gene of human immunodeficiency virus type 1

      JOURNAL OF VIROLOGY
    20. Kovacs, JA; Imamichi, H; Vogel, S; Metcalf, JA; Dewar, RL; Baseler, M; Stevens, R; Adelsberger, J; Lambert, L; Davey, RT; Walker, RE; Falloon, J; Polis, MA; Masur, H; Lane, HC
      Effects of intermittent interleukin-2 therapy on plasma and tissue human immunodeficiency virus levels and quasi-species expression

      JOURNAL OF INFECTIOUS DISEASES
    21. Emery, S; Capra, WB; Cooper, DA; Mitsuyasu, RT; Kovacs, JA; Vig, P; Smolskis, M; Saravolatz, LD; Lane, HC; Fyfe, GA; Curtin, PT
      Pooled analysis of 3 randomized, controlled trials of interleukin-2 therapy in adult human immunodeficiency virus type 1 disease

      JOURNAL OF INFECTIOUS DISEASES
    22. Fogelman, I; Davey, V; Ochs, HD; Elashoff, M; Feinberg, MB; Mican, J; Siegel, JP; Sneller, M; Lane, HC
      Evaluation of CD4(+) T cell function in vivo in HIV-infected patients as measured by bacteriophage phiX174 immunization

      JOURNAL OF INFECTIOUS DISEASES
    23. Losso, MH; Belloso, WH; Emery, S; Benetucci, JA; Cahn, PE; Lasala, MC; Lopardo, G; Salomon, H; Saracco, M; Nelson, E; Law, MG; Davey, RT; Allende, MC; Lane, HC
      A randomized, controlled, phase II trial comparing escalating doses of subcutaneous interleukin-2 plus antiretrovirals versus antiretrovirals alone in human immunodeficiency virus-infected patients with CD4(+) cell counts >=350/mm(3)

      JOURNAL OF INFECTIOUS DISEASES
    24. Walker, RE; Bechtel, CM; Natarajan, V; Baseler, M; Hege, KM; Metcalf, JA; Stevens, R; Hazen, A; Blaese, RM; Chen, CC; Leitman, SF; Palensky, J; Wittes, J; Davey, RT; Falloon, J; Polis, MA; Kovacs, JA; Broad, DF; Levine, BL; Roberts, MR; Masur, H; Lane, HC
      Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection

      BLOOD
    25. Whitcup, SM; Fortin, E; Lindblad, AS; Griffiths, P; Metcalf, JA; Robinson, MR; Manischewitz, J; Baird, B; Perry, C; Kidd, IM; Vrabec, T; Davey, RT; Falloon, J; Walker, RE; Kovacs, JA; Lane, HC; Nussenblatt, RB; Smith, J; Masur, H; Polis, MA
      Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis

      ARCHIVES OF OPHTHALMOLOGY
    26. Gea-Banacloche, JC; Lane, HC
      Lymphocyte turnover in the setting of HIV infection

      IMMUNOLOGIST
    27. Chun, TW; Engel, D; Mizell, SB; Hallahan, CW; Fischette, M; Park, S; Davey, RT; Dybul, M; Kovacs, JA; Metcalf, JA; Mican, JM; Berrey, MM; Corey, L; Lane, HC; Fauci, AS
      Effect of interleukin-2 on the pool of latently infected, resting CD4(+) Tcells in HIV-1-infected patients receiving highly active anti-retroviral therapy

      NATURE MEDICINE
    28. Crandall, KA; Kelsey, CR; Imamichi, H; Lane, HC; Salzman, NP
      Parallel evolution of drug resistance in HIV: Failure of nonsynonymous/synonymous substitution rate ratio to detect selection

      MOLECULAR BIOLOGY AND EVOLUTION
    29. Falloon, J; Sargent, S; Piscitelli, SC; Bechtel, C; LaFon, SW; Sadler, B; Walker, RE; Kovacs, JA; Polis, MA; Davey, RT; Lane, HC; Masur, H
      Atovaquone suspension in HIV-infected volunteers: Pharmacokinetics, pharmacodynamics, and TMP-SMX interaction study

      PHARMACOTHERAPY
    30. Gea-Banacloche, JC; Lane, HC
      Immune reconstitution in HIV infection

      AIDS
    31. Natarajan, V; Bosche, M; Metcalf, JA; Ward, DJ; Lane, HC; Kovacs, JA
      HIV-1 replication in patients with undetectable plasma virus receiving HEART

      LANCET
    32. Whitcup, SM; Fortin, E; Lindblad, AS; Griffiths, P; Metcalf, JA; Robinson, MR; Manischewitz, J; Baird, B; Perry, C; Kidd, IM; Vrabec, T; Davey, RT; Falloon, J; Walker, RE; Kovacs, JA; Lane, HC; Nussenblatt, RB; Smith, J; Masur, H; Polis, MA
      Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    33. Highbarger, HC; Alvord, WG; Jiang, MK; Shah, AS; Metcalf, JA; Lane, HC; Dewar, RL
      Comparison of the Quantiplex version 3.0 assay and a sensitized Amplicor Monitor assay for measurement of human immunodeficiency virus type 1 RNA levels in plasma samples

      JOURNAL OF CLINICAL MICROBIOLOGY
    34. Chun, TW; Davey, RT; Engel, D; Lane, HC; Fauci, AS
      AIDS - Re-emergence of HIV after stopping therapy

      NATURE
    35. Davey, RT; Bhat, N; Yoder, C; Chun, TW; Metcalf, JA; Dewar, R; Natarajan, V; Lempicki, RA; Adelsberger, JW; Millers, KD; Kovacs, JA; Polis, MA; Walker, RE; Falloon, L; Masur, H; Gee, D; Baseler, M; Dimitrov, DS; Fauci, AS; Lane, HC
      HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    36. Davey, RT; Chaitt, DG; Albert, JM; Piscitelli, SC; Kovacs, JA; Walker, RE; Falloon, J; Polis, MA; Metcalf, JA; Masur, H; Dewar, R; Baseler, M; Fyfe, G; Giedlin, MA; Lane, HC
      A randomized trial of high- versus low-dose subcutaneous interleukin-2 outpatient therapy for early human immunodeficiency virus type 1 infection

      JOURNAL OF INFECTIOUS DISEASES
    37. WALKER RE; CARTER CS; MUUL L; NATARAJAN V; HERPIN BR; LEITMAN SF; KLEIN HG; MULLEN CA; METCALF JA; BASELER M; FALLOON J; DAVEY RT; KOVACS JA; POLIS MA; MASUR H; BLAESE RM; LANE HC
      PERIPHERAL EXPANSION OF PREEXISTING MATURE T-CELLS IS AN IMPORTANT MEANS OF CD4(-CELL REGENERATION HIV-INFECTED ADULTS() T)

      Nature medicine
    38. MATANO T; SHIBATA R; SIEMON C; CONNORS M; LANE HC; MARTIN MA
      ADMINISTRATION OF AN ANTI-CD8 MONOCLONAL-ANTIBODY INTERFERES WITH THECLEARANCE OF CHIMERIC SIMIAN HUMAN IMMUNODEFICIENCY VIRUS DURING PRIMARY INFECTIONS OF RHESUS MACAQUES/

      Journal of virology
    39. GEABANACLOCHE JC; WEISKOPF EE; HALLAHAN C; DEQUIROS JCLB; FLANIGAN M; MICAN JM; FALLOON J; BASELER M; STEVENS R; LANE HC; CONNORS M
      PROGRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE IS ASSOCIATED WITH INCREASING DISRUPTIONS WITHIN THE CD4(-CELL RECEPTOR REPERTOIRE() T)

      The Journal of infectious diseases
    40. NUSSENBLATT RB; LANE HC
      HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE - CHANGING PATTERNS OF INTRAOCULAR INFLAMMATION

      American journal of ophthalmology
    41. CONNORS M; LANE HC
      HIV ANTIVIRALS AND IMMUNE RECOVERY - REPLY

      Nature medicine
    42. CONNORS M; KOVACS JA; KREVAT S; GEABANACLOCHE JC; SNELLER MC; FLANIGAN M; METCALF JA; WALKER RE; FALLOON J; BASELER M; STEVENS R; FEUERSTEIN I; MASUR H; LANE HC
      HIV-INFECTION INDUCES CHANGES IN CD4(-CELL PHENOTYPE AND DEPLETIONS WITHIN THE CD4(+) T-CELL REPERTOIRE THAT ARE NOT IMMEDIATELY RESTORED BY ANTIVIRAL OR IMMUNE-BASED THERAPIES() T)

      Nature medicine
    43. MANN M; SHELHAMER JH; MASUR H; GILL VJ; TRAVIS W; SOLOMON D; MANISCHEWITZ J; STOCK F; LANE HC; OGNIBENE FP
      LACK OF CLINICAL UTILITY OF BRONCHOALVEOLAR LAVAGE CULTURES FOR CYTOMEGALOVIRUS IN HIV-INFECTION

      American journal of respiratory and critical care medicine
    44. EMERY S; LANE HC
      IMMUNE RECONSTITUTION IN HIV-INFECTION

      Current opinion in immunology
    45. SHIBATA R; SIEMON C; RIZVI TA; MATANO T; SATTERFIELD WC; LANE HC; MARTIN MA
      REACTIVATION OF HIV TYPE-I IN CHRONICALLY INFECTED CHIMPANZEES FOLLOWING XENOSTIMULATION WITH HUMAN-CELLS OR WITH PULSES OF CORTICOSTEROID

      AIDS research and human retroviruses
    46. WENG NP; PALMER LD; LEVINE BL; LANE HC; JUNE CH; HODES RJ
      TALES OF TAILS - REGULATION OF TELOMERE LENGTH AND TELOMERASE ACTIVITY DURING LYMPHOCYTE DEVELOPMENT, DIFFERENTIATION, ACTIVATION, AND AGING

      Immunological reviews
    47. LEMPICKI RA; PAVLICK MV; DONOGHUE ET; KOVACS J; ADELESBERGER J; BASELER M; LANE HC
      IL-2 RELIEVES G(1) CELL-CYCLE ARREST IN CD8-CELLS FROM HIV+ INDIVIDUALS( T)

      Journal of allergy and clinical immunology
    48. WOOD LV; WIGGINTON JM; ZUCKERMAN J; HIGHAM C; LOY S; BROUWERS P; LANE HC; TOWNLEY E; JANKELEVICH S; SERCHUK L; SEI S; ZEICHNER S
      A PILOT-STUDY OF RECOMBINANT IL-2 IN CHILDREN AND ADOLESCENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION

      Journal of allergy and clinical immunology
    49. POLIS MA; PISCITELLI SC; VOGEL S; WITEBSKY FG; CONVILLE PS; PETTY B; KOVACS JA; DAVEY RT; WALKER RE; FALLOON J; METCALF JA; CRAFT C; LANE HC; MASUR H
      CLARITHROMYCIN LOWERS PLASMA ZIDOVUDINE LEVELS IN PERSONS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION

      Antimicrobial agents and chemotherapy
    50. KOVACS JA; DAVEY RT; LANE HC
      INTERLEUKIN-2 INFUSIONS IN HIV-INFECTED PATIENTS - REPLY

      The New England journal of medicine
    51. ZHANG YM; IMAMICHI H; IMAMICHI T; LANE HC; FALLOON J; VASUDEVACHARI MB; SALZMAN NP
      DRUG-RESISTANCE DURING INDINAVIR THERAPY IS CAUSED BY MUTATIONS IN THE PROTEASE GENE AND IN ITS GAG SUBSTRATE CLEAVAGE SITES

      Journal of virology
    52. DAVEY RT; CHAITT DG; PISCITELLI SC; WELLS M; KOVACS JA; WALKER RE; FALLOON J; POLIS MA; METCALF JA; MASUR H; FYFE G; LANE HC
      SUBCUTANEOUS ADMINISTRATION OF INTERLEUKIN-2 IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PERSONS

      The Journal of infectious diseases
    53. PALMER LD; WENG NP; LEVINE BL; JUNE CH; LANE HC; HODES RJ
      TELOMERE LENGTH, TELOMERASE ACTIVITY, AND REPLICATIVE POTENTIAL IN HIV-INFECTION - ANALYSIS OF CD4(-CELLS FROM HIV-DISCORDANT MONOZYGOTIC TWINS() AND CD8(+) T)

      The Journal of experimental medicine
    54. KLAUSNER JD; MAKONKAWKEYOON S; AKARASEWI P; NAKATA K; KASINRERK W; CORRAL L; DEWAR RL; LANE HC; FREEDMAN VH; KAPLAN G
      THE EFFECT OF THALIDOMIDE ON THE PATHOGENESIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND MYCOBACTERIUM-TUBERCULOSIS INFECTION

      Journal of acquired immune deficiency syndromes and human retrovirology
    55. SPOONER KM; LANE HC; MASUR H
      GUIDE TO MAJOR CLINICAL-TRIALS OF ANTIRETROVIRAL THERAPY ADMINISTEREDTO PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS

      Clinical infectious diseases
    56. MORGAN RA; WALKER R; BLAESE RM; CARTER CS; DAVEY RT; FALLOON J; KLEIN H; LANE HC; LEITMAN SF; POLIS MA
      GENE-THERAPY FOR AIDS USING RETROVIRAL-MEDIATED GENE-TRANSFER TO DELIVER HIV-1 ANTISENSE TAR AND TRANSDOMINANT REV PROTEIN GENES TO SYNGENEIC LYMPHOCYTES IN HIV-1-INFECTED IDENTICAL-TWINS

      Human gene therapy
    57. DRUSANO GL; AWEEKA F; GAMBERTOGLIO J; JACOBSON M; POLIS M; LANE HC; EATON C; MARTINMUNLEY S
      RELATIONSHIP BETWEEN FOSCARNET EXPOSURE, BASE-LINE CYTOMEGALOVIRUS (CMV) BLOOD CULTURE AND THE TIME TO PROGRESSION OF CMV RETINITIS IN HIV-POSITIVE PATIENTS

      AIDS
    58. LANE HC
      HAS IMMUNOTHERAPY COME OF AGE

      AIDS
    59. DAVEY RT; CHAITT DG; REED GF; FREIMUTH WW; HERPIN BR; METCALF JA; EASTMAN PS; FALLOON J; KOVACS JA; POLIS MA; WALKER RE; MASUR H; BOYLE J; COLEMAN S; COX SR; WATHEN L; DAENZER CL; LANE HC
      RANDOMIZED, CONTROLLED PHASE I II TRIAL OF COMBINATION THERAPY WITH DELAVIRDINE (U-90152S) AND CONVENTIONAL NUCLEOSIDES IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PATIENTS/

      Antimicrobial agents and chemotherapy
    60. RUXRUNGTHAM K; BOONE E; FORD H; DRISCOLL JS; DAVEY RT; LANE HC
      POTENT ACTIVITY OF 2'-BETA-FLUORO-2',3'-DIDEOXYADENOSINE AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION IN HU-PBL-SCID MICE

      Antimicrobial agents and chemotherapy
    61. KOVACS JA; VOGEL S; ALBERT JM; FALLOON J; DAVEY RT; WALKER RE; POLIS MA; SPOONER K; METCALF JA; BASELER M; FYFE G; LANE HC
      CONTROLLED TRIAL OF INTERLEUKIN-2 INFUSIONS IN PATIENTS INFECTED WITHTHE HUMAN-IMMUNODEFICIENCY-VIRUS

      The New England journal of medicine
    62. SHIBATA R; SIEMON C; CHO MW; ARTHUR LO; NIGIDA SM; MATTHEWS T; SAWYER LA; SCHULTZ A; MURTHY KK; ISRAEL Z; JAVADIAN A; FROST P; KENNEDY RC; LANE HC; MARTIN MA
      RESISTANCE OF PREVIOUSLY INFECTED CHIMPANZEES TO SUCCESSIVE CHALLENGES WITH A HETEROLOGOUS INTRACLADE B-STRAIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1

      Journal of virology
    63. WALKER RE; SPOONER KM; KELLY G; MCCLOSKEY V; WOODY JN; FALLOON J; BASELER M; PISCITELLI SC; DAVEY RT; POLIS MA; KOVACS JA; MASUR H; LANE HC
      INHIBITION OF IMMUNOREACTIVE TUMOR-NECROSIS-FACTOR-ALPHA BY A CHIMERIC ANTIBODY IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1

      The Journal of infectious diseases
    64. KOVACS JA; BECHTEL C; DAVEY RT; FALLOON J; POLIS MA; WALKER RE; METCALF JA; DAVEY V; PISCITELLI SC; BASELER M; DEWAR R; SALZMAN NP; MASUR H; LANE HC
      COMBINATION THERAPY WITH DIDANOSINE AND INTERFERON-ALPHA IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS - RESULTS OF A PHASE I II TRIAL/

      The Journal of infectious diseases
    65. KOENIG S; CONLEY AJ; BREWAH YA; JONES GM; LEATH S; BOOTS LJ; DAVEY V; PANTALEO G; DEMAREST JF; CARTER C; WANNEBO C; YANNELLI JR; ROSENBERG SA; LANE HC
      TRANSFER OF HIV-1-SPECIFIC CYTOTOXIC T-LYMPHOCYTES TO AN AIDS PATIENTLEADS TO SELECTION FOR MUTANT HIV VARIANTS AND SUBSEQUENT DISEASE PROGRESSION

      Nature medicine
    66. LANE HC
      THE ROLE OF IMMUNE-BASED THERAPIES IN THE CONTEXT OF CONVENTIONAL ANTIRETROVIRAL THERAPY

      Journal of acquired immune deficiency syndromes and human retrovirology
    67. SPOONER KM; LANE HC; MASUR H
      ANTIRETROVIRAL THERAPY - REFERENCE GUIDE TO MAJOR CLINICAL-TRIALS IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS

      Clinical infectious diseases
    68. CONNORS M; BOYLE MJ; FLANIGAN ME; GEIGER SP; FORD H; BASELER M; ADELSBERGER J; DAVEY RT; LANE HC
      THE HU-HIV PBL-SCID MOUSE - A MODIFIED HU-PBL-SCID MODEL FOR THE STUDY OF HIV PATHOGENESIS AND THERAPY/

      The FASEB journal
    69. LANE HC; DAVEY RT
      DIAGNOSIS OF HIV-INFECTION

      Immunology and allergy clinics of North America
    70. WALKER RE; CARTER CS; MUUL L; NATARAJAN V; HERPIN BR; LEITMAN SF; KLEIN HG; FALLOON J; DAVEY RT; KOVACS JA; POLIS MA; MASUR H; BLAESE RM; LANE HC
      SURVIVAL AND DISTRIBUTION OF GENETICALLY-MODIFIED CELLS IN IDENTICAL-TWINS DISCORDANT FOR HIV-1 INFECTION

      AIDS research and human retroviruses
    71. LANE HC
      THE GENERATION OF CD4 T-LYMPHOCYTES IN PATIENTS WITH HIV-INFECTION

      Journal of biological regulators and homeostatic agents
    72. POLIS MA; SPOONER KM; BAIRD BF; MANISCHEWITZ JF; JAFFE HS; FISHER PE; FALLOON J; DAVEY RT; KOVACS JA; WALKER RE; WHITCUP SM; NUSSENBLATT RB; LANE HC; MASUR H
      ANTICYTOMEGALOVIRAL ACTIVITY AND SAFETY OF CIDOFOVIR IN PATIENTS WITHHUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND CYTOMEGALOVIRUS VIRURIA

      Antimicrobial agents and chemotherapy
    73. LANE HC; KOVACS JA
      INTERLEUKIN-2 AS THERAPY FOR HIV DISEASE - REPLY

      The New England journal of medicine
    74. KOVACS JA; BASELER M; DEWAR RJ; VOGEL S; DAVEY RT; FALLOON J; POLIS MA; WALKER RE; STEVENS R; SALZMAN NP; METCALF JA; MASUR H; LANE HC
      INCREASES IN CD4 T-LYMPHOCYTES WITH INTERMITTENT COURSES OF INTERLEUKIN-2 IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - A PRELIMINARY-STUDY

      The New England journal of medicine
    75. SHIBATA R; HOGGAN MD; BROSCIUS C; ENGLUND G; THEODORE TS; BUCKLERWHITE A; ARTHUR LO; ISRAEL Z; SCHULTZ A; LANE HC; MARTIN MA
      ISOLATION AND CHARACTERIZATION OF A SYNCYTIUM-INDUCING, MACROPHAGE T-CELL LINE-TROPIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATE THAT READILY INFECTS CHIMPANZEE CELLS IN-VITRO AND IN-VIVO/

      Journal of virology
    76. BOYLE MJ; CONNORS M; FLANIGAN ME; GEIGER SP; FORD H; BASELER M; ADELSBERGER J; DAVEY RT; LANE HC
      THE HUMAN HIV PERIPHERAL-BLOOD LYMPHOCYTE (PBL)-SCID MOUSE - A MODIFIED HUMAN PBL-SCID MODEL FOR THE STUDY OF HIV PATHOGENESIS AND THERAPY

      The Journal of immunology
    77. LANE HC; POLIS MA; MURPHY R; NUSSENBLATT AB; MASUR H
      PHOSPHONOFORMATE FOR CMV RETINITIS IN AIDS - REPLY

      The American journal of medicine
    78. NATARAJAN V; PLISHKA RJ; SCOTT EW; LANE HC; SALZMAN NP
      AN INTERNALLY CONTROLLED VIRION PCR FOR THE MEASUREMENT OF HIV-1 RNA IN PLASMA

      PCR methods and applications
    79. LEMPICKI RA; TANI Y; GEIGER S; LANE HC; ZOLLAPAZNER S; COHEN DI
      EVALUATION OF T-LYMPHOCYTES EXPRESSING GENETICALLY-ENGINEERED HIV-ENVSPECIFIC RECEPTORS AS AN EFFECTIVE THERAPY FOR HIV-1 INFECTION

      The FASEB journal
    80. LEMPICKI RA; TANI Y; GEIGER S; ZOLLAPAZNER S; LANE HC; COHEN DI
      EVALUATION OF T-LYMPHOCYTES EXPRESSING GENETICALLY-ENGINEERED HIV-ENVSPECIFIC RECEPTORS AS AN EFFECTIVE THERAPY FOR HIV-1 INFECTION

      AIDS research and human retroviruses
    81. BURTON DR; BARBAS CF; BINLEY JM; DITZEL H; HENDRY M; LANE HC; WALKER R; MOORE JP; NARA PM; NORRBY E; THALI M; SODROSKI J
      RECOMBINANT NEUTRALIZING HUMAN-ANTIBODIES TO HIV-1

      Journal of cellular biochemistry
    82. SNELLER MC; EISENSTEIN EM; BASELER M; LANE HC; DONOGHUE ET; FALLOON J
      A UNIQUE SYNDROME OF IMMUNODEFICIENCY AND AUTOIMMUNITY ASSOCIATED WITH ABSENT T-CELL CD2 EXPRESSION

      Journal of clinical immunology
    83. LANE HC
      INTERFERONS IN HIV AND RELATED DISEASES

      AIDS
    84. FALLOON J; LAVELLE J; OGATAARAKAKI D; BYRNE A; GRAZIANI A; MORGAN A; AMANTEA MA; OWNBY K; POLIS M; DAVEY RT; KOVACS JA; LANE HC; MASUR H; MACGREGOR RR
      PHARMACOKINETICS AND SAFETY OF WEEKLY DAPSONE AND DAPSONE PLUS PYRIMETHAMINE FOR PREVENTION OF PNEUMOCYSTIS PNEUMONIA

      Antimicrobial agents and chemotherapy
    85. TANI Y; DONOGHUE E; SHARPE S; BOONE E; LANE HC; ZOLLAPAZNER S; COHEN DI
      ENHANCED IN-VITRO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION IN B-CELLS EXPRESSING SURFACE ANTIBODY TO THE TM ENV PROTEIN

      Journal of virology
    86. ZHANG YM; DAWSON SC; LANDSMAN D; LANE HC; SALZMAN NP
      PERSISTENCE OF 4 RELATED HUMAN-IMMUNODEFICIENCY-VIRUS SUBTYPES DURINGTHE COURSE OF ZIDOVUDINE THERAPY - RELATIONSHIP BETWEEN VIRION RNA AND PROVIRAL DNA

      Journal of virology
    87. DEWAR RL; HIGHBARGER HC; SARMIENTO MD; TODD JA; VASUDEVACHARI MB; DAVEY RT; KOVACS JA; SALZMAN NP; LANE HC; URDEA MS
      APPLICATION OF BRANCHED DNA SIGNAL AMPLIFICATION TO MONITOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BURDEN IN HUMAN PLASMA

      The Journal of infectious diseases
    88. DAVEY RT; BOENNING CM; HERPIN BR; BATTS DH; METCALF JA; WATHEN L; COX SR; POLIS MA; KOVACS JA; FALLOON J; WALKER RE; SALZMAN N; MASUR H; LANE HC
      USE OF RECOMBINANT SOLUBLE CD4 PSEUDOMONAS EXOTOXIN, A NOVEL IMMUNOTOXIN, FOR TREATMENT OF PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS

      The Journal of infectious diseases
    89. SCHNITTMAN SM; VOGEL S; BASELER M; LANE HC; DAVEY RT
      A PHASE-I STUDY OF INTERFERON-ALPHA-2B IN COMBINATION WITH INTERLEUKIN-2 IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION

      The Journal of infectious diseases
    90. LANE HC; LAUGHON BE; FALLOON J; KOVACS JA; DAVEY RT; POLIS MA; MASUR H
      RECENT ADVANCES IN THE MANAGEMENT OF AIDS-RELATED OPPORTUNISTIC INFECTIONS

      Annals of internal medicine
    91. WALKER R; BLAESE RM; CARTER CS; CHANG L; KLEIN H; LANE HC; LEITMAN SF; MULLEN CA; LARSON M
      A STUDY OF THE SAFETY AND SURVIVAL OF THE ADOPTIVE TRANSFER OF GENETICALLY MARKED SYNGENEIC LYMPHOCYTES IN HIV-INFECTED IDENTICAL-TWINS

      Human gene therapy
    92. LANE HC
      IMMUNOLOGICAL APPROACHES TO THE THERAPY OF PATIENTS WITH HIV-1 INFECTION

      Journal of acquired immune deficiency syndromes
    93. TANI Y; BOONE E; DONOHUE E; ZOLLAPAZNER S; LANE HC; COHEN DI
      EXPRESSION OF AN ANTI-GP41 RECEPTOR ON THE SURFACE OF A B-CELL ASSOCIATED WITH ENHANCED REPLICATION OF HIV-1

      Journal of acquired immune deficiency syndromes
    94. SOUDEYNS H; PANTALEO GP; BOGHOSSIAN T; CIURLI C; REBAI N; LANE HC; FAUCI AS; SEKALY RP
      V-BETA-SPECIFIC VARIATIONS IN THE T-CELL RECEPTOR REPERTOIRE OF HIV-INFECTED SUBJECTS SUGGEST THE PRESENCE OF AN HIV-ASSOCIATED SUPERANTIGEN

      Journal of cellular biochemistry
    95. VASUDEVACHARI MB; SALZMAN NP; WOLL DR; MAST C; UFFELMAN KW; TOEDTER G; HOEFHEINZ D; METCALF JA; LANE HC
      CLINICAL UTILITY OF AN ENHANCED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 P24 ANTIGEN CAPTURE ASSAY

      Journal of clinical immunology
    96. DAVEY RT; DEWAR RL; REED GF; VASUDEVACHARI MB; POLIS MA; KOVACS JA; FALLOON J; WALKER RE; MASUR H; HANEIWICH SE; ONEILL DG; DECKER MR; METCALF JA; DELORIA MA; LASKIN OL; SALZMAN N; LANE HC
      PLASMA VIREMIA AS A SENSITIVE INDICATOR OF THE ANTIRETROVIRAL ACTIVITY OF L-697,661

      Proceedings of the National Academy of Sciences of the United Statesof America
    97. MASUR H; POLIS MA; TUAZON CU; OGATAARAKAKI D; KOVACS JA; KATZ D; HILT D; SIMMONS T; FEUERSTEIN I; LUNDGREN B; LANE HC; CHABNER BA; ALLEGRA CJ
      SALVAGE TRIAL OF TRIMETREXATE-LEUCOVORIN FOR THE TREATMENT OF CEREBRAL TOXOPLASMOSIS IN PATIENTS WITH AIDS

      The Journal of infectious diseases
    98. TANI Y; TIAN H; LANE HC; COHEN DI
      NORMAL T-CELL RECEPTOR-MEDIATED SIGNALING IN T-CELL LINES STABLY EXPRESSING HIV-1 ENVELOPE GLYCOPROTEINS

      The Journal of immunology
    99. SOUDEYNS H; PANTALEO GP; BOGHOSSIAN T; CIURLI C; REBAI N; LANE HC; FAUCI AS; SEKALY RP
      V-BETA-SPECIFIC VARIATIONS IN THE TCR REPERTOIRE OF HIV-INFECTED SUBJECTS SUGGEST THE PRESENCE OF AN HIV-ASSOCIATED SUPERANTIGEN

      The Journal of immunology
    100. SCULLY G; MCCOY SM; COHEN DI; LANE HC
      THE ROLE OF VPU IN THE PATHOGENESIS OF HIV-1 INFECTION

      The Journal of immunology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/05/20 alle ore 14:23:53